शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
ZYDUSLIFENSEZydus Lifesciences Limited· Pharmaceuticals & BiotechnologyHighPositive
Announced Thu, 21 May, 2026 · 13:10 IST

Zydus Lifesciences Limited has informed the Exchange regarding 'Public Announcement on Buyback'.

Buyback at over 10% premiumCorporate Actions View source PDFExplain this filing

ZYDUSLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.3%Reaction day
₹1040.30
prior close
₹1039.00
announcement price
In-mkt
timing
Nifty 100market · index membership as recorded later (tracked since Jun 2026)+0.0%-0.4% vs market
Pharmaceuticals peers, median of 160sector+0.2%-0.5% vs sector

On the reaction day the stock moved 0.4 pts less than Nifty 100 and 0.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.1
10m
-0.0
15m
-0.2
30m
-0.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.3+0.0-0.4+0.2-0.5
Next day
-0.2+0.3-0.5+0.2-0.3
2d
+3.0+1.7+1.3+1.4+1.5
3d
+3.5+1.3+2.2+1.3+2.2
4d
+4.5+1.5+2.9+1.6+2.9
5d
+4.0+0.1+3.9+1.0+3.0
1w
+3.8-0.4+4.2+0.2+3.6
15d
+6.0+0.0+6.0+0.5+5.6
1m
+4.4+2.5+1.8+2.8+1.5
2m
+10.2+2.7+7.4+6.9+3.2
3m
+7.7+3.3+4.4+8.2-0.5
UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 160Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zydus Lifesciences Limited has announced a buyback of up to 95,65,217 equity shares (0.95% of total paid-up capital) at INR 1,150 per share. The total buyback size is INR 1,100 crore (INR 1,100 crores). The buyback price represents a premium of 23.88% on NSE and 23.33% on BSE over the volume weighted average market price. Record date is fixed as May 29, 2026, and the tender period will run from June 4, 2026 to June 10, 2026. The company states the buyback is aimed at distributing surplus cash to shareholders, optimizing returns and enhancing overall shareholder value. Promoter and promoter group hold approximately 75.46% of shares and may participate in the buyback.

Likely market impact

The buyback at a 24% premium to market price is positive for shareholders as it offers an exit opportunity at attractive pricing. It signals management confidence in the company's financial health and is expected to support the stock price near-term.